1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Avisyn Pharma, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

CA US

Primary Industry

Pharmaceuticals

About

Founded in 2016 and based in California, US, Avisyn Pharma, Inc. operates as a provider of drug discovery and development programs. The company was formed by major-pharma scientists from AstraZeneca and Vertex. Avisyn Pharma, Inc. is a sister company of IntelliSyn Pharma, Inc. The company provides drug discovery support services through Flex-Sourcing, for companies with limited or zero chemistry lab space, In-Sourcing, for companies with existing, under-utilized lab space in San Diego and looking to increase resourcing, and Out-Sourcing, for companies needing expert med chem and synthesis support from its Montreal labs.
Current Investors
X-Chem, Inc.

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.avisyn.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Deals

Deals Type
Add-on
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Avisyn Pharma, Inc. 26 Jan 2021
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.